Shyamakant Giri
CEO, Gland Pharma
Notable Quotes
We are confident of achieving a mid-teens growth in the coming couple of years.
Cenexi reached break-even this quarter. We are confident Synapse's performance will continue to improve.
Our long-term vision on ROW is the strongest. We internally have reason to believe that this business can double over the next three to five years.
We are estimating now third quarter FY26 could be a bit of a positive quarter.